A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency. Blood sample tests for ...
A new test has been developed in Turku, Finland, that helps in separating heart attack patients from those whose cardiac troponin values are elevated due to renal insufficiency. Blood sample tests for ...
A single troponin level measurement test and an electrocardiogram may be sufficient to rule out the risk of a heart attack in patients complaining of chest pain, according to a study in the Journal of ...
Please provide your email address to receive an email when new articles are posted on . “Our study suggests that patients are routinely discharged from the ED after a single negative troponin test ...
A single high-sensitivity cardiac troponin T (hs-cTnT) test with findings below the level of detection, teamed with a nonischemic electrocardiogram (ECG), can identify patients with chest pain in the ...
Preliminary results with a point-of-care test developed to assess cardiac troponin I (cTnI) in saliva rather than blood have shown cTnl can be detected in the saliva of patients with proven myocardial ...
High-sensitivity cardiac troponin testing can identify patients with stable coronary artery disease who have a greater risk for MI or cardiovascular death, a study conducted in Scotland indicates.
A study published in the European Heart Journal could help predict the likelihood of dementia up to 25 years in advance. The research found a link between increased levels of cardiac troponin, a ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Transitioning ...
The diagnostics advisory committee considered evidence on high-sensitivity troponin tests for the early rule out of non-ST-segment elevation myocardial infarction (NSTEMI) from several sources. Full ...
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs ...
The committee heard from a patient expert who highlighted the stresses and fears that patients and their families experience when attending the emergency department with chest pain. Reducing waiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback